Our findings were similar to the retrospective study by Zimmerman et al.27, which enrolled 105,862 T2DM patients to compare GLP-1 RA exposure to no exposure in a real-world setting. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.